Moderate low-carb diet safe and effective for adults with type 1 diabetes

A moderate low-carbohydrate diet for adults with type 1 diabetes has advantages over traditional diet.

Zealand’s ‘aspirational’ mission for its amylin drug to be first-line in obesity

SAN ANTONIO — Zealand Pharma, hoping to create the next “foundational” therapy for obesity, detailed more Phase 1 data on its amylin analog that was

November 6, 2024

As Pfizer slashes revenue projections, Moderna says it “remains comfortable”

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

October 17, 2023

Counter-culture or pharma: Group behind MDMA therapy for PTSD wrestles with its identity

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in

June 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.